Integrated Management of Patients with Diabetes Mellitus and Ischemic Heart Disease: PCI, CABG, and Medical Therapy

Detre, 1977, Effect of coronary bypass surgery on longevity in high and low risk patients. Report from the VA Cooperative Coronary Surgery Study, Lancet, 2, 1243, 10.1016/S0140-6736(77)92659-9 1979, Coronary-artery bypass surgery in stable angina pectoris, Lancet, 1, 889 1982, Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris, Lancet, 2, 1173 1983, Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data., Circulation, 68, 939, 10.1161/01.CIR.68.5.939 1984, Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial, N Engl J Med, 310, 750, 10.1056/NEJM198403223101204 Myers, 1989, Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry, J Thorac Cardiovasc Surg, 97, 487, 10.1016/S0022-5223(19)34538-6 Takaro, 1982, Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease, Circulation, 66, 14, 10.1161/01.CIR.66.1.14 Alderman, 1983, Results of coronary artery surgery in patients with poor left ventricular function (CASS), Circulation, 68, 785, 10.1161/01.CIR.68.4.785 Passamani, 1985, A randomized trial of coronary artery bypass surgery, N Engl J Med, 312, 1665, 10.1056/NEJM198506273122603 Chaitman, 1986, The role of coronary bypass surgery for ‘left main equivalent’ coronary disease, Circulation, 74 Luchi, 1987, Comparison of medical and surgical treatment for unstable angina pectoris, N Engl J Med, 316, 977, 10.1056/NEJM198704163161603 Detre, 1981, Effect of bypass surgery on survival in patients in low- and high-risk subgroups delineated by the use of simple clinical variables, Circulation, 63, 1329, 10.1161/01.CIR.63.6.1329 Varnauskas, 1988, Twelve-year follow-up of survival in the randomized European coronary surgery study, N Engl J Med, 319, 332, 10.1056/NEJM198808113190603 Yusuf, 1994, Effect of coronary artery bypass graft surgery on survival, Lancet, 344, 563, 10.1016/S0140-6736(94)91963-1 1993, Coronary angioplasty versus coronary artery bypass surgery, Lancet, 341, 573, 10.1016/0140-6736(93)90348-K Goy, 1994, Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis, Lancet, 343, 1449, 10.1016/S0140-6736(94)92579-8 1995, First-year results of CABRI (coronary angioplasty versus bypass revascularisation investigation), Lancet, 346, 1179, 10.1016/S0140-6736(95)92896-0 Rodriguez, 1993, Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group, J Am Coll Cardiol, 22, 1060, 10.1016/0735-1097(93)90416-X Carrie, 1997, Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery disease, Circulation, 96 Hueb, 1995, The Medicine, Angioplasty or Surgery Study (MASS), J Am Coll Cardiol, 26, 1600, 10.1016/0735-1097(95)00384-3 Hamm, 1994, A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI), N Engl J Med, 331, 1037, 10.1056/NEJM199410203311601 King, 1994, A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST), N Engl J Med, 331, 1044, 10.1056/NEJM199410203311602 1996, Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease, N Engl J Med, 335, 217, 10.1056/NEJM199607253350401 Pocock, 1995, Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery, Lancet, 346, 1184, 10.1016/S0140-6736(95)92897-9 Hlatky, 2004, Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease, Circulation, 110, 1960, 10.1161/01.CIR.0000143379.26342.5C Mark, 1994, Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease. A prospective comparison study, Ann Intern Med, 120, 111, 10.7326/0003-4819-120-2-199401150-00003 Hlatky, 1995, Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI), Am J Cardiol, 75, 34C, 10.1016/S0002-9149(99)80393-2 Kolkka, 1980, Neurologic dysfunction following cardiac operation with low-flow, low-pressure cardiopulmonary bypass, J Thorac Cardiovasc Surg, 79, 432, 10.1016/S0022-5223(19)37952-8 Hlatky, 1997, Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery, Circulation, 96 Jones, 1996, Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease, J Thorac Cardiovasc Surg, 111, 1013, 10.1016/S0022-5223(96)70378-1 Mark, 1994, Continuing evolution of therapy for coronary artery disease, Circulation, 89, 2015, 10.1161/01.CIR.89.5.2015 1997, Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease, Circulation, 96, 1761, 10.1161/01.CIR.96.6.1761 O’Neill, 1998, Multivessel balloon angioplasty should be abandoned in diabetic patients, J Am Coll Cardiol, 31, 20 Ferguson, 1995, NHLBI BARI clinical alert on diabetics treated with angioplasty, Circulation, 92, 3371, 10.1161/01.CIR.92.12.3371 2000, Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status, J Am Coll Cardiol, 35, 1122, 10.1016/S0735-1097(00)00533-7 Harris, 1996, Early detection of undiagnosed non-insulin-dependent diabetes mellitus, J Am Med Assoc, 276, 1261, 10.1001/jama.1996.03540150063033 Narayan, 2003, Lifetime risk for diabetes mellitus in the United States, JAMA, 290, 1884, 10.1001/jama.290.14.1884 Dunstan, 2002, The rising prevalence of diabetes and impaired glucose tolerance, Diabetes Care, 25, 829, 10.2337/diacare.25.5.829 Shaw, 2000, Type 2 diabetes worldwide according to the new classification and criteria, Diabetes Care, 23, B5 Wild, 2004, Global prevalence of diabetes, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 Kjekshus, 1996, Treating the diabetic patient with coronary artery disease, Eur Heart J, 17, 1298, 10.1093/oxfordjournals.eurheartj.a015059 Nathan, 1993, Long-term complications of diabetes mellitus, N Engl J Med, 328, 1676, 10.1056/NEJM199306103282306 Barbash, 1993, Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy, J Am Coll Cardiol, 22, 707, 10.1016/0735-1097(93)90180-9 Orlander, 1994, The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project, Diabetes, 43, 897, 10.2337/diab.43.7.897 Jelesoff, 1996, Outcomes of diabetic patients following acute myocardial infarction, Coron Artery Dis, 7, 732, 10.1097/00019501-199610000-00006 Jacoby, 1992, Acute myocardial infarction in the diabetic patient, J Am Coll Cardiol, 20, 736, 10.1016/0735-1097(92)90033-J Iwasaka, 1994, Residual left ventricular pump function following acute myocardial infarction in postmenopausal diabetic women, Coron Artery Dis, 5, 237, 10.1097/00019501-199403000-00009 Goraya, 2002, Coronary atherosclerosis in diabetes mellitus, J Am Coll Cardiol, 40, 946, 10.1016/S0735-1097(02)02065-X Gu, 1999, Diabetes and decline in heart disease mortality in US adults, JAMA, 281, 1291, 10.1001/jama.281.14.1291 American Heart Association. Heart Disease and Stroke Statistics—2004 Update. Dallas, TX: American Heart Association, 2003. Bloomgarden, 2004, Type 2 diabetes in the young, Diabetes Care, 27, 998, 10.2337/diacare.27.4.998 Brodsky, 2004, Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by Ebselen, Circ Res, 94, 377, 10.1161/01.RES.0000111802.09964.EF Brownlee, 1988, Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications, N Engl J Med, 318, 1315, 10.1056/NEJM198805193182007 Yan, 2003, Glycation, inflammation, and RAGE, Circ Res, 93, 1159, 10.1161/01.RES.0000103862.26506.3D Ceriello, 1995, Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress, Diabetes, 44, 924, 10.2337/diab.44.8.924 Basta, 2002, Advanced glycation end products activate endothelium through signal-transduction receptor RAGE, Circulation, 105, 816, 10.1161/hc0702.104183 Hink, 2001, Mechanisms underlying endothelial dysfunction in diabetes mellitus, Circ Res, 88, 14e, 10.1161/01.RES.88.2.e14 Barsness, 2000, Lesion progression and restenosis in PTCA-treated diabetic and non-diabetic patients with multivessel disease, Circulation, 18 Rozenman, 1997, Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation, J Am Coll Cardiol, 30, 1420, 10.1016/S0735-1097(97)00342-2 Silva, 1995, Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients, Circulation, 92, 1731, 10.1161/01.CIR.92.7.1731 Barsness, 2000, Issues and challenges with antithrombotic therapy in diabetic patients with acute coronary syndromes, Curr Cardiol Rep, 2, 411, 10.1007/s11886-000-0054-x McGuire, 2000, Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study, Eur Heart J, 21, 1750, 10.1053/euhj.2000.2317 Roffi, 2001, Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes, Circulation, 104, 2767, 10.1161/hc4801.100029 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Despres, 1996, Hyperinsulinemia as an independent risk factor for ischemic heart disease, N Engl J Med, 334, 952, 10.1056/NEJM199604113341504 Sobel, 1996, Potentiation of vasculopathy by insulin, Circulation, 93, 1613, 10.1161/01.CIR.93.9.1613 1970, A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results, Diabetes, 19, 787 Sowers, 1993, Hyperinsulinemia, insulin resistance, and hyperglycemia, Am J Hypertens, 6, 260S, 10.1093/ajh/6.7.260S Haffner, 2000, Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects, Circulation, 101, 975, 10.1161/01.CIR.101.9.975 Hsueh, 2003, Role of endothelial dysfunction in insulin resistance, Am J Cardiol, 92, 10J, 10.1016/S0002-9149(03)00611-8 Verdecchia, 2004, Adverse prognostic significance of new diabetes in treated hypertensive subjects, Hypertension, 43, 963, 10.1161/01.HYP.0000125726.92964.ab Fernandez-Real, 2003, Insulin resistance and chronic cardiovascular inflammatory syndrome, Endocr Rev, 24, 278, 10.1210/er.2002-0010 Festa, 2003, Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion, Circulation, 108, 1822, 10.1161/01.CIR.0000091339.70120.53 Singleton, 2003, Microvascular complications of impaired glucose tolerance, Diabetes, 52, 2867, 10.2337/diabetes.52.12.2867 Girman, 2004, The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS), Am J Cardiol, 93, 136, 10.1016/j.amjcard.2003.09.028 Barsness, 1997, Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty, Circulation, 96, 2551, 10.1161/01.CIR.96.8.2551 Mathew, 2004, Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era, Circulation, 109, 476, 10.1161/01.CIR.0000109693.64957.20 Levine, 1994, The impact of diabetes mellitus on restenosis following directional coronary atherectomy and PTCA, Circulation, 90 Rabbani, 1994, Relation of restenosis after excimer laser angioplasty to fasting insulin levels, Am J Cardiol, 73, 323, 10.1016/0002-9149(94)90002-7 Weintraub, 1993, Can restenosis after coronary angioplasty be predicted from clinical variables?, J Am Coll Cardiol, 21, 6, 10.1016/0735-1097(93)90711-9 Hassinger, 1996, Outcomes and their predictors after PTCA in patients with type II diabetes mellitus, Circulation, 94 Holmes, 1996, Eight year, long term outcome after PTCA: factors associated with adverse events. The NHLBI PTCA registry, J Am Coll Cardiol, 27, 361A, 10.1016/S0735-1097(96)82362-X Mueller, 1992, Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction, Circulation, 85, 1254, 10.1161/01.CIR.85.4.1254 Stein, 1995, Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty, Circulation, 91, 979, 10.1161/01.CIR.91.4.979 Ellis, 1990, Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease, Circulation, 82, 1193, 10.1161/01.CIR.82.4.1193 Vandormael, 1991, Predictors of long-term cardiac survival in patients with multivessel coronary artery disease undergoing percutaneous transluminal coronary angioplasty, Am J Cardiol, 67, 1, 10.1016/0002-9149(91)90089-4 Bach, 1994, Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty, Thromb Res, 74, S55, 10.1016/S0049-3848(10)80007-6 Kip, 1996, Coronary angioplasty in diabetic patients, Circulation, 94, 1818, 10.1161/01.CIR.94.8.1818 Anderson, 1996, The association between a history of diabetes and outcome in patients undergoing percutaneous interventions, Circulation Frid, 1991, The effect of diabetes on restenosis, J Am Coll Cardiol, 17, 268A, 10.1016/0735-1097(91)92038-N Kubal, 2005, Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery, Ann Thorac Surg, 79, 1570, 10.1016/j.athoracsur.2004.10.035 Singh, 2002, Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention, J Am Coll Cardiol, 40, 387, 10.1016/S0735-1097(02)01980-0 Rihal, 2003, Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina, Circulation, 108, 2439, 10.1161/01.CIR.0000094405.21583.7C Solomon, 1998, Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials, Ann Intern Med, 128, 216, 10.7326/0003-4819-128-3-199802010-00008 Savage, 2005, Mechanisms of insulin resistance in humans and possible links with inflammation, Hypertension, 45, 828, 10.1161/01.HYP.0000163475.04421.e4 Prior, 2005, Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus, Circulation, 111, 01, 10.1161/01.CIR.0000164232.62768.51 Dandona, 2005, Metabolic syndrome, Circulation, 111, 1448, 10.1161/01.CIR.0000158483.13093.9D Schaumberg, 2005, Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial, Circulation, 111, 2446, 10.1161/01.CIR.0000165064.31505.3B Duncan, 2003, Low-grade systemic inflammation and the development of type 2 diabetes, Diabetes, 52, 1799, 10.2337/diabetes.52.7.1799 Moreno, 2000, Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus, Circulation, 102, 2180, 10.1161/01.CIR.102.18.2180 Bucciarelli, 2002, RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice, Circulation, 106, 2827, 10.1161/01.CIR.0000039325.03698.36 Waller, 1980, Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects, Am J Med, 69, 498, 10.1016/S0149-2918(05)80002-5 Vavuranakis, 1997, Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients. An in vivo intravascular ultrasound study, Eur Heart J, 18, 1090, 10.1093/oxfordjournals.eurheartj.a015402 Kornowski, 1997, Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study, Circulation, 95, 1366, 10.1161/01.CIR.95.6.1366 Gilbert, 2004, Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting, Diabetes Care, 27, 990, 10.2337/diacare.27.4.990 Reichard, 1994, Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study, Diabetes, 43, 313, 10.2337/diab.43.2.313 Juhan-Vague, 1993, Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris, Arterioscler Thromb, 13, 1865, 10.1161/01.ATV.13.12.1865 Letchacovski, 1995, Enhanced platelet thrombus formation in diabetic compared to non-diabetic patients, Circulation, 92 Bruno, 1996, Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus, Ann Intern Med, 125, 653, 10.7326/0003-4819-125-8-199610150-00005 Benchimol, 1993, Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty, Int J Cardiol, 38, 7, 10.1016/0167-5273(93)90198-P Margolis, 1984, Coronary angioplasty, Circulation, 70 Corpus, 2004, Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention, J Am Coll Cardiol, 43, 8, 10.1016/j.jacc.2003.06.019 Corpus, 2003, Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization, Am J Cardiol, 92, 1282, 10.1016/j.amjcard.2003.08.008 Garratt, 1999, Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction, J Am Coll Cardiol, 33, 119, 10.1016/S0735-1097(98)00557-9 Rolka, 2001, Aspirin use among adults with diabetes, Diabetes Care, 24, 197, 10.2337/diacare.24.2.197 Gunnett, 2003, Gene-targeted mice reveal a critical role for inducible nitric oxide synthase in vascular dysfunction during diabetes, Stroke, 34, 2970, 10.1161/01.STR.0000099123.55171.3F Ceriello, 2004, Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited, Arterioscler Thromb Vasc Biol, 24, 816, 10.1161/01.ATV.0000122852.22604.78 Tan, 2002, Advanced glycation end products and endothelial dysfunction in type 2 diabetes, Diabetes Care, 25, 1055, 10.2337/diacare.25.6.1055 Kawagishi, 1999, Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes, Arterioscler Thromb Vasc Biol, 19, 2509, 10.1161/01.ATV.19.10.2509 Hsueh, 2003, The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease, Am J Cardiol, 92, 3J, 10.1016/S0002-9149(03)00610-6 Tschoepe, 1991, Large platelets circulate in an activated state in diabetes mellitus, Semin Thromb Hemost, 17, 433, 10.1055/s-2007-1002650 Keating, 2003, Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus, Am J Cardiol, 92, 1362, 10.1016/j.amjcard.2003.08.033 Sacco, 2003, Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients, Diabetes Care, 26, 3264, 10.2337/diacare.26.12.3264 Osende, 2001, Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control, J Am Coll Cardiol, 38, 1307, 10.1016/S0735-1097(01)01555-8 Singh, 2001, Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience), Am J Cardiol, 88, 1091, 10.1016/S0002-9149(01)02040-9 Hochberg, 2002, Haptoglobin phenotype and coronary artery collaterals in diabetic patients, Atherosclerosis, 161, 441, 10.1016/S0021-9150(01)00657-8 Levy, 2002, Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes, J Am Coll Cardiol, 40, 1984, 10.1016/S0735-1097(02)02534-2 Moreno, 1999, Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients, J Am Coll Cardiol, 34, 1045, 10.1016/S0735-1097(99)00338-1 Van Belle, 2001, Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up, Circulation, 103, 1218, 10.1161/01.CIR.103.9.1218 Legrand, 2004, Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease, Circulation, 109, 1114, 10.1161/01.CIR.0000118504.61212.4B Weintraub, 1998, Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease, J Am Coll Cardiol, 31, 10, 10.1016/S0735-1097(97)00441-5 Detre, 1999, Coronary revascularization in diabetic patients, Circulation, 99, 633, 10.1161/01.CIR.99.5.633 Berger, 2001, Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI), J Am Coll Cardiol, 38, 1440, 10.1016/S0735-1097(01)01571-6 Bell, 1990, Percutaneous transluminal angioplasty in patients with multivessel coronary disease, J Am Coll Cardiol, 16, 553, 10.1016/0735-1097(90)90342-M Nikolsky, 2004, Percutaneous coronary interventions in diabetic patients, J Invasive Cardiol, 16, 102 Bourassa, 1998, Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA Registry, Eur Heart J, 19, 103, 10.1053/euhj.1997.0574 Bourassa, 1999, Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI), J Am Coll Cardiol, 33, 1627, 10.1016/S0735-1097(99)00077-7 Bell, 1992, Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery, Circ Res, 86, 446, 10.1161/01.CIR.86.2.446 Detre, 2000, The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators, N Engl J Med, 342, 989, 10.1056/NEJM200004063421401 Sobel, 2001, Acceleration of restenosis by diabetes, Circulation, 103, 1185, 10.1161/01.CIR.103.9.1185 King, 1997, Angioplasty or surgery for multivessel coronary artery disease, J Am Coll Cardiol, 30, 180 1992, Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina, Circulation, 86, 121, 10.1161/01.CIR.86.1.121 Peduzzi, 1998, Twenty-two-year follow-up in the VA Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina, Am J Cardiol, 81, 1393, 10.1016/S0002-9149(98)00204-5 Parisi, 1992, A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease, N Engl J Med, 326, 10, 10.1056/NEJM199201023260102 Henderson, 2003, Seven-year outcome in the RITA-2 trial, J Am Coll Cardiol, 42, 1161, 10.1016/S0735-1097(03)00951-3 Pitt, 1999, Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators, N Engl J Med, 341, 70, 10.1056/NEJM199907083410202 Reichard, 1993, The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus, N Engl J Med, 329, 304, 10.1056/NEJM199307293290502 Malmberg, 1996, Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction, Eur Heart J, 17, 1337, 10.1093/oxfordjournals.eurheartj.a015067 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Orchard, 2003, Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes, Diabetes Care, 26, 1374, 10.2337/diacare.26.5.1374 Jamerson, 2000, Treating high-risk hypertensive patients, Am J Hypertens, 13, 68S, 10.1016/S0895-7061(00)00270-3 Gaede, 2003, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N Engl J Med, 348, 383, 10.1056/NEJMoa021778 Snow, 2004, Lipid control in the management of type 2 diabetes mellitus, Ann Intern Med, 140, 644, 10.7326/0003-4819-140-8-200404200-00012 1998, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes, BMJ, 317, 713, 10.1136/bmj.317.7160.713 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes, BMJ, 317, 703, 10.1136/bmj.317.7160.703 Haffner, 1998, Management of dyslipidemia in adults with diabetes, Diabetes Care, 21, 160, 10.2337/diacare.21.1.160 Steiner, 2000, Lipid intervention trials in diabetes, Diabetes Care, 23, B49 Haffner, 1999, Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels, Arch Intern Med, 159, 2661, 10.1001/archinte.159.22.2661 Pyorala, 1997, Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S), Diabetes Care, 20, 614, 10.2337/diacare.20.4.614 Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS), Lancet, 364, 685, 10.1016/S0140-6736(04)16895-5 Wilson, 2004, Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention, Diabetes Care, 27, 1137, 10.2337/diacare.27.5.1137 Holmes, 2004, Analysis of 1-year clinical outcomes in the SIRIUS trial, Circulation, 109, 634, 10.1161/01.CIR.0000112572.57794.22 Schofer, 2003, Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries, Lancet, 362, 1093, 10.1016/S0140-6736(03)14462-5 Moussa, 2004, Impact of sirolimus-eluting stents on outcome in diabetic patients, Circulation, 109, 2273, 10.1161/01.CIR.0000129767.45513.71 Van Belle, 2002, Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients, J Am Coll Cardiol, 40, 410, 10.1016/S0735-1097(02)01971-X Abizaid, 2001, Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients, Circulation, 104, 533, 10.1161/hc3101.093700 Abizaid, 2004, Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial, Eur Heart J, 25, 107, 10.1016/j.ehj.2003.11.002 Velianou, 2000, Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation, Am J Cardiol, 86, 1063, 10.1016/S0002-9149(00)01160-7 Bhatt, 2000, Abciximab reduces mortality in diabetics following percutaneous coronary intervention, J Am Coll Cardiol, 35, 922, 10.1016/S0735-1097(99)00650-6 Kuntz, 1999, Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy, Circulation, 99, 847, 10.1161/01.CIR.99.7.847 Nissen, 2003, Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes, JAMA, 290, 2292, 10.1001/jama.290.17.2292 Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 Moreno, 2004, New aspects in the pathogenesis of diabetic atherothrombosis, J Am Coll Cardiol, 44, 2293, 10.1016/j.jacc.2004.07.060 Singh, 2000, Improving outcome over time of percutaneous coronary interventions in unstable angina, J Am Coll Cardiol, 36, 674, 10.1016/S0735-1097(00)00768-3 Aldea, 1998, Comparison of risk profile and outcomes in patients undergoing surgical and catheter-based revascularization, J Card Surg, 13, 81, 10.1111/j.1540-8191.1998.tb01238.x Marso, 1999, Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus, Circulation, 100, 2477, 10.1161/01.CIR.100.25.2477 Brener, 2004, Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features, Circulation, 109, 2290, 10.1161/01.CIR.0000126826.58526.14 Emberson, 2005, Coronary heart disease prevention in clinical practice, Heart, 91, 451, 10.1136/hrt.2004.035832 Davies, 1997, Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up, Circulation, 95, 2037, 10.1161/01.CIR.95.8.2037 Caracciolo, 1996, Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study, Circulation, 93, 2097, 10.1161/01.CIR.93.12.2097 1997, Coronary angioplasty versus medical therapy for angina, Lancet, 350, 461, 10.1016/S0140-6736(97)07298-X Boden, 1998, Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy, N Engl J Med, 338, 1785, 10.1056/NEJM199806183382501 1999, Invasive compared with non-invasive treatment in unstable coronary-artery disease, Lancet, 354, 708, 10.1016/S0140-6736(99)07349-3 Sobel, 2003, Burgeoning dilemmas in the management of diabetes and cardiovascular disease, Circulation, 107, 636, 10.1161/01.CIR.0000048897.03553.E4